UMG's Board of Directors recommends paying out EUR 38 million in interim dividends for 6M 2021
Cyprus, 30 November 2021. United Medical Group CY PLC (hereinafter referred to as "the Company", together with its subsidiaries, "the Group" or "EMC", MOEX ticker: GEMC), a leading provider of comprehensive premium medical services in Russia, operating under the brand "European Medical Center", hereby informs that at a meeting on 29 November 2021, the Company’s Board of Directors recommended interim dividends for the six months ended 30 June 2021 be distributed in the amount of EUR 38.4 million at a rate of EUR 0.4269 per share. This recommendation is fully in line with the Company’s previously announced plans to pay out guaranteed dividends in the amount of EUR 114 million in 2021.
The ex-dividend date is set on December 15, 2021.
In addition to the dividends’ distribution, the Board of Directors approved the budget for the fiscal year of 2022, Amendments to the existing Regulations on Insider Information and the List of Insider Information of the Company, long-term incentive program for the Management.
About the company
EMC is a leading multidisciplinary provider of premium healthcare services in Russia with the longest track record of any major private healthcare business in this market. EMC is a fully integrated healthcare services provider offering a comprehensive range of diversified medical services, and has advanced capabilities in more than 57 specialisations, differentiating it from the competition in Russia. The company utilises a patient-centric approach to its healthcare services offering, which allows it to provide patients with a full range of diagnostics and treatment services as well as offer tailor-made medical care.
EMC also is a leading Russian provider of cancer treatment with extensive expertise in a full range of modern oncology treatment methods, state-of-the-art facilities and equipment as well as renowned experts with international experience.
EMC’s network comprises seven multidisciplinary medical centres, one maternity centre and one rehabilitation centre (with a total built-up area of approximately 87 thousand square metres), as well as three geriatric centres (with a total built-up area of approximately 14 thousand square metres). As at 30 June 2021, the Group had 2,593 employees, comprising 752 physicians, 1,472 nurses and other medical staff and 369 administrative and support staff.
Company’s depository receipts have traded on Moscow Exchange since July 15, 2021, under the ticker “GEMC”.
About the company
EMC is a leading multidisciplinary provider of premium healthcare services in Russia with the longest track record of any major private healthcare business in this market.[ According to EMC’s estimates.] EMC is a fully integrated healthcare services provider offering a comprehensive range of diversified medical services, and has advanced capabilities in more than 57 specialisations, differentiating it from the competition in Russia. The company utilises a patient-centric approach to its healthcare services offering, which allows it to provide patients with a full range of diagnostics and treatment services as well as offer tailor-made medical care.
EMC also is a leading Russian provider of cancer treatment with extensive expertise in a full range of modern oncology treatment methods, state-of-the-art facilities and equipment as well as renowned experts with international experience.
EMC’s network comprises seven multidisciplinary medical centres, one maternity centre and one rehabilitation centre (with a total built-up area of approximately 87 thousand square metres), as well as three geriatric centres (with a total built-up area of approximately 14 thousand square metres).
Company’s depository receipts have traded on Moscow Exchange since July 15, 2021, under the ticker “GEMC”.
Investor relations
Dmitry Ivanov
Head of Investor Relations
Important Note
NEITHER THIS ANNOUNCEMENT NOR THE INFORMATION CONTAINED HEREIN IS FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR TO ANY PERSON IN ANY OF THOSE JURISDICTIONS OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE LAWS OF SUCH JURISDICTION.
These materials are not intended to and do not constitute investment advice. These materials do not constitute or form any part of and should not be constructed as an offer or commitment to sell or issue, a solicitation, recommendation, commitment or invitation to subscribe for, underwrite or otherwise acquire, and should not be construed as an advertisement for, any securities of United Medical Group CY PLC or any member of its group in any jurisdiction or an inducement to enter into investment activity in any jurisdiction.